Breast Hypertrophy and outcome of Breast Reduction Surgery
Sammanfattning
Aim: The overall aim of this thesis was to improve our knowledge of breast
hypertrophy in women, its associated problems, and the outcome of breast
reduction.
Patients and methods: I. Five hundred and twelve woman were studied
retrospectively for prevalence of and risk factors for complications. II. The
study included 325 women, either randomized to prophylactic antibiotics or
not. III. The Breast Evaluation Questionnaire (BEQ) for women with breast
hypertrophy and breast reduction was validated. Two hundred and twentyfive
women who had had breast reduction surgery and 216 controls were
included. IV. Three hundred and forty-eight women were evaluated for gain
in health-related quality of life (HRQL) after breast reduction surgery in this
prospective, longitudinal paired study.Results: I. A long suprasternal notch
to nipple distance increased the risk of infection and necrosis of the nipple.
High BMI increased the risk of wound infection. A larger weight of resection
increased the risk of delayed wound healing and fat necrosis. Smokers have
twice the risk of getting a postoperative infection and diabetics are at higher
risk of nipple necrosis. II. The incidence of postoperative infections was not
significantly different between the groups. III. The modified BEQ is valid
and shows good reliability. IV. Breast hypertrophy is associated with low
HRQL, and breast reduction surgery increases HRQL. Conclusions: I. Sternal
notch to nipple distance, BMI, resection weight, diabetes mellitus, and
smoking are independent risk factors for complications after breast reduction
surgery. II. One prophylactic dose of 2 g intravenous Cloxacillin or 600 mg
Clindamycin did not reduce the incidence of postoperative infections. III.
The BEQ has proven to be valid and to have good stability after being modified
(mBEQ), when used before and after breast reduction surgery. IV.
Women with breast hypertrophy have reduced quality of life and the HRQL
is strongly increased or normalized after breast reduction surgery when SF-
36, mBEQ, BRSQ, and BREAST-Q are analyzed. Those with a higher body
mass index, a longer sternal notch to nipple distance, a larger preoperative
breast volume, or large volume of breast resection enjoy gains in healthrelated
quality of life that are similar to, although probably not greater than,
other women.
Delarbeten
I) Lewin R, Göransson M, Elander A, Thorarinsson A, Lundberg J, Lidén M. Risk factors for complications after breast reduction surgery. J Plast Surg Hand Surg. 2014;48:10-14 ::PMID::23627557 II) Lewin R, Elander A, Thorarinsson A, Kölby L, Sahlin P-E, Lundberg J, Panczel A, Lidén M. A Randomized Prospective Study of Prophylactic Cloxacillin in Breast Reduction Surgery.
Annals of Plastic Surgery 2015; Jan;74(1):17-21 ::PMID::25305230 III) Lewin R, Elander A, Lundberg J, Thorarinsson A, Claudelin M, Bladh H, Lidén M. Validation of the Breast Evaluation Questionnaire for women subjected to breast reduction surgery. Submitted 2016 IV) Lewin R, Lidén M, Selvaggi G, Lundberg J, Thorarinsson A, Elander A. Prospective
evaluation of health after breast-reduction surgery using BREAST-Q, SF-36, BRSQ and modified BEQ. Manuscript
Examinationsnivå
Doctor of Philosophy (Medicine)
Universitet
University of Gothenburg. Sahlgrenska Academy
Institution
Institute of Clincial Sciences. Department of Plastic Surgery
Disputation
Torsdagen den 3 mars, kl 13.00, Aulan Sahlgrenska, Blå stråket 5, Göteborg
Datum för disputation
2016-03-03
E-post
richard.lewin@vgregion.se
Datum
2016-02-09Författare
Lewin, Richard
Nyckelord
Breast
Reduction
Mammaplasty
HRQL
Complications
Validation
Reliability
Breast Hypertrophy
Questionnaire
Publikationstyp
Doctoral thesis
ISBN
978-91-628-9706-2 (PDF)
978-91-628-9706-2 (PRINT)
Språk
eng